Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Shares To Open Lower Ahead Of BoE Minutes

Wed, 23rd Jul 2014 06:40

LONDON (Alliance News) - UK stocks are set to open slightly lower Wednesday, as geopolitical tensions remain a key market driver ahead of the release of the latest Bank of England policy meeting minutes at 0930 BST that will provide the domestic focus of the morning.

After rallying 1.0% to a two-week high on Tuesday, futures indicate that the FTSE 100 will open about 0.1% lower Wednesday at 6,783 points.

Stocks in the UK and Europe made strong gains on Tuesday, as European leaders appeared unable to agree on the immediate imposition of harsher sanctions against Russia, which also would hurt their own economies, in response to the situation in eastern Ukraine.

Although there is still a possibility that further sanctions will be announced before the end of the month, a disagreement between EU leaders over the sale of arms to Russia appeared to hamper progress at Tuesday's meeting in Brussels. Moreover, US officials Wednesday said they can't find any evidence of direct Russian involvement in the MH17 crash.

With US earnings season hitting its peak, equity markets there yet again pushed to new all-time highs, with the S&P 500 breaking new ground and closing up 0.5% at 1,983.53, the DJIA closing up 0.4% at 17,113.54, and the Nasdaq Composite up 0.7% at 4,456.016.

Stocks have been mixed in Asia Wednesday, with the Nikkei closing down 0.1% but the Hang Seng continuing up 0.6% and the Shanghai Composite up 0.3%.

The violence between Israel and Hamas in Gaza continues to escalate, and amid a heightened nervousness in the aviation industry, a whole host of airlines, including easyJet, have reportedly followed the move made by Delta on Tuesday and cancelled flights to Tel Aviv following the explosion of a Hamas rocket near the airport.

The UK economy and its monetary policy will be in focus Monday, with the release of the minutes from the July 9 and 10 Bank of England policy meeting at 0930 BST, followed by a speech from BoE Governor Mark Carney at the Commonwealth Games Business Conference in Glasgow at 1245 BST.

The Monetary Policy Committee members voted at the latest meeting to keep rates at the historic low of 0.5%, as they have done every month for almost five-and-a-half years. However, whether the UK reaches six years under the current emergency monetary policy is debatable.

Wednesday's minutes will offer a new insight, given that July was the first time new Monetary Policy Committee member Kristin Forbes has voted. Forbes replaced Ben Broadbent, who has retained a vote, having been promoted to Deputy Governor after Charlie Bean's recent retirement.

Sterling and central bank watchers will be very interested to find out where the new member sits on the dove-hawk spectrum of the nine rate-setters. It's not entirely inconceivable that Forbes will have wanted to make an early impact and voted immediately in favour of a rate hike, but the consensus expectation is for a 9-0 vote in favour of taking no action to have been recorded.

The BoE has made clear that it is slack UK wage growth that is currently causing the most concern, so any discussion had by the committee with regard to average earnings will be of most interest Wednesday morning.

Otherwise the data calendar is relatively empty Wednesday, with just weekly US MBA mortgage applications at midday, and the eurozone consumer confidence index for July at 1500 BST.

In the UK corporate calendar Wednesday, full-year results have been released from FTSE 250 listed engineer Renishaw, along with interim results from Capita and AIM-listed Staffline Group. Interim management statements have also been released by Sage Group, Talk Talk Telecom, Brewin Dolphin and Charles Stanley. GlaxoSmithKline is scheduled to release first-quarter numbers at midday.

By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.